Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

That’s why empowering local voices within global teams is mission critical. It’s not just about having someone in the seat; ...

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

Muscular dystrophy refers to a group of rare, genetic, progressive diseases that primarily affect the body’s muscles, causing ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

The US Food and Drug Administration (FDA) has unveiled a new programme that will reduce its review time for certain drug ...